Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.

Hans-Joachim SchmollJulia MannFabian MeinertBenjamin GarlippKersten BorchertArndt VogelEray GoekkurtUlrich KaiserHeinz-Gert HoeffkesJörn RüsselStephan KanzlerThomas EdelmannHelmut ForstbauerThomas GöhlerCarla HannigBert HildebrandtCarsten RollCarsten BokemeyerJörg SteighardtFranziska CygonStefan IbachAlexander SteinJoseph Tintelnot

Published in: British journal of cancer (2023)

The trial was registered as NCT01321957.

Keyphrases

metastatic colorectal cancer
phase iii
study protocol
phase ii
clinical trial
randomized controlled trial